These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30166241)

  • 21. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
    Piccolo F; Moore SA; Ford GC; Campbell KP
    Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.
    Poudel BH; Fletcher S; Wilton SD; Aung-Htut M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.
    Matsuda C; Kameyama K; Tagawa K; Ogawa M; Suzuki A; Yamaji S; Okamoto H; Nishino I; Hayashi YK
    J Neuropathol Exp Neurol; 2005 Apr; 64(4):334-40. PubMed ID: 15835269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy.
    Demonbreun AR; Fahrenbach JP; Deveaux K; Earley JU; Pytel P; McNally EM
    Hum Mol Genet; 2011 Feb; 20(4):779-89. PubMed ID: 21127009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B.
    Hogarth MW; Defour A; Lazarski C; Gallardo E; Diaz Manera J; Partridge TA; Nagaraju K; Jaiswal JK
    Nat Commun; 2019 Jun; 10(1):2430. PubMed ID: 31160583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset.
    Kesari A; Fukuda M; Knoblach S; Bashir R; Nader GA; Rao D; Nagaraju K; Hoffman EP
    Am J Pathol; 2008 Nov; 173(5):1476-87. PubMed ID: 18832576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
    Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
    Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysferlin and animal models for dysferlinopathy.
    Kobayashi K; Izawa T; Kuwamura M; Yamate J
    J Toxicol Pathol; 2012 Jun; 25(2):135-47. PubMed ID: 22907980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption.
    Demonbreun AR; Allen MV; Warner JL; Barefield DY; Krishnan S; Swanson KE; Earley JU; McNally EM
    Am J Pathol; 2016 Jun; 186(6):1610-22. PubMed ID: 27070822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin-deficient and mdx mice.
    White Z; Theret M; Milad N; Tung LW; Chen WW; Sirois MG; Rossi F; Bernatchez P
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):544-560. PubMed ID: 34927367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy.
    Ono H; Suzuki N; Kanno SI; Kawahara G; Izumi R; Takahashi T; Kitajima Y; Osana S; Nakamura N; Akiyama T; Ikeda K; Shijo T; Mitsuzawa S; Nagatomi R; Araki N; Yasui A; Warita H; Hayashi YK; Miyake K; Aoki M
    Mol Ther; 2020 Apr; 28(4):1133-1153. PubMed ID: 32087766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysferlin-mediated phosphatidylserine sorting engages macrophages in sarcolemma repair.
    Middel V; Zhou L; Takamiya M; Beil T; Shahid M; Roostalu U; Grabher C; Rastegar S; Reischl M; Nienhaus GU; Strähle U
    Nat Commun; 2016 Sep; 7():12875. PubMed ID: 27641898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.
    Chiu YH; Hornsey MA; Klinge L; Jørgensen LH; Laval SH; Charlton R; Barresi R; Straub V; Lochmüller H; Bushby K
    Hum Mol Genet; 2009 Jun; 18(11):1976-89. PubMed ID: 19286669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy.
    Patel NJ; Van Dyke KW; Espinoza LR
    Am J Med Sci; 2017 May; 353(5):484-491. PubMed ID: 28502335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysferlinopathy Fibroblasts Are Defective in Plasma Membrane Repair.
    Matsuda C; Kiyosue K; Nishino I; Goto Y; Hayashi YK
    PLoS Curr; 2015 Oct; 7():. PubMed ID: 26579332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteasome inhibitors increase missense mutated dysferlin in patients with muscular dystrophy.
    Azakir BA; Erne B; Di Fulvio S; Stirnimann G; Sinnreich M
    Sci Transl Med; 2014 Aug; 6(250):250ra112. PubMed ID: 25143362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Faster regeneration associated to high expression of Fam65b and Hdac6 in dysferlin-deficient mouse.
    Ishiba R; Santos ALF; Almeida CF; Caires LC; Ribeiro AF; Ayub-Guerrieri D; Fernandes SA; Souza LS; Vainzof M
    J Mol Histol; 2019 Aug; 50(4):375-387. PubMed ID: 31218594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone.
    Fiorillo AA; Tully CB; Damsker JM; Nagaraju K; Hoffman EP; Heier CR
    Physiol Genomics; 2018 Sep; 50(9):735-745. PubMed ID: 29883261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRAF1 deficiency blunts sarcolemmal injury repair and exacerbates cardiac and skeletal muscle pathology in dystrophin-deficient mice.
    Lenhart KC; O'Neill TJ; Cheng Z; Dee R; Demonbreun AR; Li J; Xiao X; McNally EM; Mack CP; Taylor JM
    Skelet Muscle; 2015; 5():27. PubMed ID: 26301073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysferlin rescue by spliceosome-mediated pre-mRNA trans-splicing targeting introns harbouring weakly defined 3' splice sites.
    Philippi S; Lorain S; Beley C; Peccate C; Précigout G; Spuler S; Garcia L
    Hum Mol Genet; 2015 Jul; 24(14):4049-60. PubMed ID: 25904108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.